The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.

Item

http://www.wikidata.org/entity/Q38911707

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

The Role of Transoral Robotic ...... ngeal Squamous Cell Carcinoma.

@en

type

Item

label

The Role of Transoral Robotic ...... ngeal Squamous Cell Carcinoma.

@en

prefLabel

The Role of Transoral Robotic ...... ngeal Squamous Cell Carcinoma.

@en

P1476

The Role of Transoral Robotic ...... ngeal Squamous Cell Carcinoma.

@en

P2093

Basit Abjul Jawad

http://www.w3.org/2001/XMLSchema#string

Natalie Silver

http://www.w3.org/2001/XMLSchema#string

Neil D Gross

http://www.w3.org/2001/XMLSchema#string

Ryan Sload

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.

Human papillomavirus and survival of patients with oropharyngeal cancer.

Cancer statistics, 2016

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck.

Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.

A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer

P2888

s11912-016-0541-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-016-0541-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020686030

http://www.w3.org/2001/XMLSchema#string

P698

27469262

http://www.w3.org/2001/XMLSchema#string